ARWR
NASD Arrowhead Pharmaceuticals, Inc.$61.48 ↑ +0.00 (+0.00%) Trading Up from the previous close of $61.48, $1.27 below the day’s high of $62.75
- YTD change
- -7.40%
- vs 20-day SMA
- -11.49%
- vs 200-day SMA
- -15.15%
Price ranges
Price & Performance
+0.30 (+0.49%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 35.6% away from all-time highs of $95.49
- ARWR is down 7% since the beginning of the year
- ARWR is up 68% over the past 12 months
- ARWR is down 28% over the past 1 month
- 7% of all ARWR investors are betting against ARWR
ARWR reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +68.3%.
- Previous minute
- +$0.00
- Last hour
- +$1.22
- Last 5 days
- -7.20%
- vs 8-day SMA
- -4.67%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.